- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare UTI Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.25 | 1.92 |
NAV | ₹281.56 | ₹37.70 |
Fund Started | 01 Aug 2005 | 25 Jun 2018 |
Fund Size | ₹1187.02 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.25
1.92
NAV
₹281.56
₹37.70
Fund Started
01 Aug 2005
25 Jun 2018
Fund Size
₹1187.02 Cr
₹5024.00 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 43.71% | 46.52% |
3 Year | 21.05% | 24.42% |
5 Year | 27.48% | 30.00% |
1 Year
43.71%
46.52%
3 Year
21.05%
24.42%
5 Year
27.48%
30.00%
Holding Analysis
Equity | 98.47% | 97.87% |
Cash | 1.41% | 2.13% |
Equity
98.47%
97.87%
Cash
1.41%
2.13%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.29% |
Cipla Ltd. | 5.89% |
Ajanta Pharma Ltd. | 5.38% |
Dr. Reddy's Laboratories Ltd. | 4.67% |
Gland Pharma Ltd. | 3.70% |
Glenmark Pharmaceuticals Ltd. | 3.57% |
Apollo Hospitals Enterprise Ltd. | 3.55% |
Fortis Healthcare Ltd. | 3.34% |
Procter & Gamble Health Ltd. | 3.26% |
Eris Lifesciences Ltd. | 3.07% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 14.35% |
Dr. Reddy's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 8.07% |
Lupin Ltd. | 4.59% |
Aurobindo Pharma Ltd. | 4.57% |
Gland Pharma Ltd. | 4.22% |
Apollo Hospitals Enterprise Ltd. | 3.80% |
Zydus Lifesciences Ltd. | 2.93% |
Divi's Laboratories Ltd. | 2.69% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Kamal Gada | Dharmesh Kakkad |
Start Date | 02 May 2022 | 23 Feb 2021 |
Name
Kamal Gada
Dharmesh Kakkad
Start Date
02 May 2022
23 Feb 2021
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 01 Aug 2005 | 25 Jun 2018 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
01 Aug 2005
25 Jun 2018
